Edition:
India

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

1.47USD
23 Jul 2018
Change (% chg)

$0.01 (+0.68%)
Prev Close
$1.46
Open
$1.45
Day's High
$1.48
Day's Low
$1.40
Volume
12,223
Avg. Vol
42,663
52-wk High
$78.00
52-wk Low
$1.33

Select another date:

Tue, May 22 2018

BRIEF-Reshape Lifesciences Files For Mixed Shelf Of Up To $125 Mln

* RESHAPE LIFESCIENCES FILES FOR MIXED SHELF OF UP TO $125 MILLION - SEC FILING Source text: (https://bit.ly/2Ljt5n1) Further company coverage:

BRIEF-Reshape Lifesciences Announces Submission For Approval Of Reshape Balloon In Canada

* RESHAPE LIFESCIENCES ANNOUNCES SUBMISSION FOR APPROVAL OF RESHAPE BALLOON™ IN CANADA Source text for Eikon: Further company coverage:

BRIEF-Bobby Griffin To Retire From Reshape Lifesciences' Board

* RESHAPE LIFESCIENCES - ANNOUNCED THAT BOBBY I. GRIFFIN WILL RETIRE FROM BOARD OF DIRECTORS

BRIEF-Reshape Lifesciences Says Reshape Balloon Granted Registration By National Health Regulation Authority In Kingdom Of Bahrain

* RESHAPE LIFESCIENCES INC - RESHAPE BALLOON GRANTED REGISTRATION BY NATIONAL HEALTH REGULATION AUTHORITY IN KINGDOM OF BAHRAIN

BRIEF-Reshape Lifesciences Reports Qtrly Loss Per Share Of $0.45‍​

* RESHAPE LIFESCIENCES ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS

BRIEF-Reshape Lifesciences Announces $6 Million Registered Direct Offering

* RESHAPE LIFESCIENCES ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Reshape Lifesciences Reschedules Fourth Quarter And Full Year 2017 Conference Call To April 2, 2018

* RESHAPE LIFESCIENCES ANNOUNCES UPDATE ON INTEGRATION EFFORTS AND RESCHEDULES FOURTH QUARTER AND FULL YEAR 2017 CONFERENCE CALL TO APRIL 2, 2018

BRIEF-ReShape Lifesciences Agrees With Academy Medical To Provide Reshape Balloon To Department Of Defense Facilities

* RESHAPE LIFESCIENCES ANNOUNCES AGREEMENT WITH ACADEMY MEDICAL TO PROVIDE RESHAPE BALLOON AND RESHAPE VBLOC TO DEPARTMENT OF DEFENSE FACILITIES

BRIEF-ReShape Lifesciences Q4 Preliminary Revenue About $795,000

* RESHAPE LIFESCIENCES REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 REVENUE

Select another date: